Premium
Metabolic syndrome in androgenetic alopecia patients; Is serum regulated on activation, normal T‐cell expressed and secreted the missing link?
Author(s) -
Mustafa Amany Ibraim,
Abel Halim Walid Abd Ellatif,
Eman Fawzy,
Doaa ElHabbak
Publication year - 2021
Publication title -
journal of cosmetic dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.626
H-Index - 44
eISSN - 1473-2165
pISSN - 1473-2130
DOI - 10.1111/jocd.13802
Subject(s) - pathogenesis , metabolic syndrome , national cholesterol education program , medicine , gastroenterology , case control study , endocrinology , obesity
Background Androgenetic alopecia (AGA) is the most common cause of hair loss affecting both men and women. There are many conflicting results about the relationship between AGA and metabolic syndrome, (MetS) and the pathogenesis of the metabolic disorders in AGA patients is not completely elucidated. Aims Evaluation of the prevalence of MetS and the possible role of RANTES in pathogenesis of the MS among AGA patients. Methods A total of 160 subjects were enrolled in this work; included 100 patients clinically diagnosed with AGA and 60 apparently healthy control subjects. They were evaluated for MS components according to National Cholesterol Education Program (NCEP) adult treatment panel 3 (ATP3) and measurement of serum RANTES level using ELISA kits. Results Metabolic syndrome was present in 30.0% of AGA patients and in 10.0% of the control group ( P = .038), Studied AGA patients showed significantly higher serum RANTES when compared to control group ( P value < .001). Moreover, serum RANTES levels were significantly positively correlated with BMI, FBG, TC, and LDL‐c levels in AGA patients with MetS. Conclusion Metabolic syndrome components were prevalent among AGA patients. Serum RANTES level was significantly higher in all AGA patients and specifically in those with MS as it was significantly positively correlated with some MetS components which reflects its possible role in pathogenesis of MetS in AGA patients.